Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Mallinckrodt
Dow
Accenture
US Department of Justice
US Army
Merck
AstraZeneca
UBS

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040578

« Back to Dashboard

NDA 040578 describes BENZPHETAMINE HYDROCHLORIDE, which is a drug marketed by Anda Repository, Emcure Pharms Ltd, Epic Pharma Llc, Impax Labs, Kvk Tech, Mikart, Specgx Llc, and Tedor Pharm, and is included in nine NDAs. It is available from fourteen suppliers. Additional details are available on the BENZPHETAMINE HYDROCHLORIDE profile page.

The generic ingredient in BENZPHETAMINE HYDROCHLORIDE is benzphetamine hydrochloride. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the benzphetamine hydrochloride profile page.
Summary for 040578
Tradename:BENZPHETAMINE HYDROCHLORIDE
Applicant:Anda Repository
Ingredient:benzphetamine hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Apr 17, 2006TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Teva
Citi
QuintilesIMS
Queensland Health
Dow
Chubb
Chinese Patent Office
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.